Neurologic Oncology News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Jill Baker
MDLinx Career Center
MGMA Data Breaks Down Physician Compensation

MDLinx Reminder
MDLinx
Did you see this newsletter?

Smartest Doc Challenge
MDLinx
Pediatric Oncology Clinical Pearls

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Transition rates for adenomas to CRC

MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?

MDLinx Conference Center
MDLinx
June Conference Calendar

New!	>> Find out who is the Smartest Doc in Oncology!

Articles

Latest (4) Full Text Articles (257) Focus on Leukemia/lymphoma

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

101 Outcome of patients with renal cell carcinoma metastatic to the brain treated with sunitinib without local therapy American Journal of Clinical Oncology, May 29, 2013 Clinical Article

102 Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system Modern Pathology, May 29, 2013 Clinical Article

103 Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme CNS Neuroscience & Therapeutics, May 29, 2013 Review Article

104 Anaplastic ganglioglioma in the spinal cord: case report and literature review Pediatric Neurosurgery, May 29, 2013

105 The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells Oncogene, May 29, 2013 Review Article

106 MicroRNA biomarkers in glioblastoma Journal of Neuro-Oncology, May 28, 2013 Review Article

107 Quinolinic acid-mediated stress resistance in malignant glioma Cancer Research, May 28, 2013 Clinical Article

108 Fatal b-cell lymphoma following Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids JAMA Neurology, May 28, 2013

109 SPAG9 is overexpressed in human astrocytoma and promotes cell proliferation and invasion Tumor Biology, May 28, 2013 Clinical Article

110 Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme American Journal of Clinical Oncology, May 28, 2013 Review Article

111 Comparative analysis of survival, treatment, cost and resource use among patients newly diagnosed with brain metastasis by initial primary cancer Journal of Neuro-Oncology, May 28, 2013 Clinical Article

112 Phosphorylation of EZH2 activates STAT3 signaling via stat3 methylation and promotes tumorigenicity of glioblastoma stem-like cells Cancer Cell, May 28, 2013 Review Article

113 Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme Neuro-Oncology, May 24, 2013

114 A simple electrodiagnostic method for morton neuroma Muscle & Nerve, May 24, 2013 Review Article

115 Expression of the G-CSF receptor, CD114, marks a novel, highly tumorigenic cell population in a neuroblastoma cell line Cancer Research, May 24, 2013 Clinical Article

116 ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas Full Text BMC Cancer, May 24, 2013 Clinical Article

117 Sluggish cognitive tempo in survivors of pediatric brain tumors Journal of Neuro-Oncology, May 24, 2013 Clinical Article

118 Mood disturbance in glioma patients Journal of Neuro-Oncology, May 24, 2013 Clinical Article

119 MR perfusion in and around the contrast-enhancement of primary CNS lymphomas Journal of Neuro-Oncology, May 24, 2013 Clinical Article

120 Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic acid-guided surgery Neurosurgery, May 24, 2013 Review Article

50 available pages First Previous 6 7 8 9 10 11 12 13 14 15 Next Last

Clinical Pearls in Oncology

The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

1 Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma Clinical Cancer Research, May 15, 2013

2 Defining pseudoprogression in glioblastoma multiforme European Journal of Neurology, May 23, 2013 Review Article

3 The Combination of Novel Targeted Molecular Agents and Radiation in the Treatment of Pediatric Gliomas Frontiers in Oncology, May 20, 2013

4 Prognostic role for diffusion-weighted imaging of pediatric optic pathway glioma Journal of Neuro-Oncology, May 23, 2013

5 Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma Journal of Neuro-Oncology, May 16, 2013

6 Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme Neuro-Oncology, May 24, 2013

7 Phase 2 study of dose-intense temozolomide in recurrent glioblastoma Neuro-Oncology, April 9, 2013

8 Glioblastoma Resistance to Anti-VEGF Therapy: Has the Challenge Been MET Clinical Cancer Research, April 3, 2013

9 Vemurafenib and radiation therapy in melanoma brain metastases Journal of Neuro-Oncology, April 30, 2013

10 Secondary hematological malignancies associated with temozolomide in patients with glioma Neuro-Oncology, March 26, 2013

11 Phase II Study of Bevacizumab and Temsirolimus Combination Therapy for Recurrent Glioblastoma Multiforme Anticancer Research, April 9, 2013

12 The molecular and cell biology of pediatric low-grade gliomas Oncogene, May 1, 2013 Review Article

13 Descriptive epidemiology of ependymal tumours in the United States British Journal of Cancer, May 13, 2013

14 Heterogeneity of neuroblastoma cell lines in IGF-1 receptor/Akt pathway-mediated cell proliferative responses Cancer Science, May 30, 2013

15 Extradural Hematoma in Children: Case Series of 33 Patients Pediatric Neurosurgery, May 20, 2013

16 Health-related quality of life in patients with brain tumors: limitations and additional outcome measures Current Neurology and Neuroscience Reports, May 22, 2013

17 Long-term outcome of centrally located low-grade glioma in children Cancer, May 7, 2013

18 Radiotherapy for Optic Nerve Sheath Meningioma: A Case for Earlier Intervention Clinical Oncology, May 13, 2013

19 Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme American Journal of Clinical Oncology, May 28, 2013 Review Article

20 Molecular Pathways: Radiation-Induced Cognitive Impairment Clinical Cancer Research, April 2, 2013 Review Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Neurologic Oncology News & Articles

Articles

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

HCC risk increased in patients with AIDS

RAB25 is a prognostic marker for ovarian cancer

Most Popular Oncology Articles

Other Topics in Oncology